Harbin Pharmaceutical Group (600664.SS) Earnings Analysis
Harbin Pharmaceutical Group (600664.SS) has no confirmed upcoming earnings date. Trailing P/E 49.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600664.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600664.SS. This page updates as the calendar is published.
600664.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.064 CNY | n/a | n/a | n/a |
| 2025-10-24 | 0.02735 CNY | n/a | n/a | n/a |
| 2025-04-26 | 0.04658 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.08 CNY | n/a | n/a | n/a |
| 2024-10-25 | 0.06548 CNY | n/a | n/a | n/a |
| 2024-08-22 | 0.06617 CNY | n/a | n/a | n/a |
600664.SS valuation and analyst view
| Trailing P/E | 49.14 |
|---|---|
| Trailing EPS | 0.12301 CNY |
| Price / book | 2.58 |
| Dividend yield | 0.00% |
| Market cap | 15.06B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Harbin Pharmaceutical Group (600664.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600664.SS. This page updates as the calendar is published.
Did 600664.SS beat earnings last quarter?
Consensus estimate data was not available for 600664.SS's 2026-04-22 report.
What is 600664.SS's current P/E ratio and EPS?
600664.SS trades at a trailing P/E of 49.14 on trailing EPS of 0.12300958592707142 CNY.
What do analysts rate 600664.SS?
600664.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.